Medicina intensiva
-
A study was made of the changes in the serum levels of thrombin activatable fibrinolysis inhibitor (TAFI), proinflammatory cytokines and acute phase proteins in the acute stage of acute coronary syndrome (ACS), in order to explore the possibility of using TAFI as a biomarker for ACS risk assessment. ⋯ These findings suggest that TAFI can be useful as a potential biomarker for ACS risk assessment.
-
Editorial Comment
Surviving the Intensive Care Units looking through the family's eyes.